Lilly To Pay Miss. $18.5M Over Zyprexa Marketing

By Christie Smythe

Law360, New York (February 04, 2010, 5:26 PM ET) -- Eli Lilly and Co. Inc. has agreed to pay Mississippi $18.5 million to settle the state's allegations that the drugmaker marketed its antipsychotic Zyprexa for off-label uses and failed to reveal risks that the drug could cause diabetes.

Mississippi Attorney General Jim Hood on Thursday announced the settlement, which has been filed with the Circuit Court of Lafayette County. Under the agreement, the drugmaker has neither admitted nor denied wrongdoing, according to a consent judgment and assurance of voluntary compliance filed with the court.

In addition...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles